NT-proBNP adds incremental predictive information on incident atrial fibrillation in patients with asymptomatic aortic stenosis

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Associate Professor Casper Bang

Novo Nordisk, Soeborg (Denmark)

32 More presentations in this session

Presentation thumbnail

Left atrial enlargement as an independent risk factor for ischemic stroke in Japanese atrial fibrillation patients: pooled analysis of five major Japanese atrial fibrillation registries

Doctor M. Akao (Kyoto, JP)

Abstract Slides

Presentation thumbnail

Diverse activation patterns during persistent atrial fibrillation characterised by dipole density non-contact mapping

Doctor R. Shi (London, GB)

Abstract Slides

Presentation thumbnail

Profibrogenic biomarkers and severity of left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome: is it possible to predict the effectiveness of therapy?

Assistant Professor V. Ionin (Saint Petersburg, RU)

Abstract Slides

Presentation thumbnail

Clinical characteristics and outcomes of atrial fibrillation patients with thrombocytopenia: the Fushimi AF Registry

Doctor K. Ishigami (Kyoto, JP)

Presentation thumbnail

Comparison of equations for renal function assessment and major adverse outcomes in atrial fibrillation: an analysis from the EORP-AF long-term general registry

Professor G. Boriani (Modena, IT)

Access the full session

Session thumbnail

Poster Session 4 - Epidemiology of atrial fibrillation

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Presentation

Interactive discussion and Q&A

Congress Session

EHRA Myths - Device-detected atrial fibrillation

Congress Presentation

Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources